153 related articles for article (PubMed ID: 33670375)
1. Patient-Specific Network for Personalized Breast Cancer Therapy with Multi-Omics Data.
Cava C; Sabetian S; Castiglioni I
Entropy (Basel); 2021 Feb; 23(2):. PubMed ID: 33670375
[TBL] [Abstract][Full Text] [Related]
2. Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy.
Flashner-Abramson E; Vasudevan S; Adejumobi IA; Sonnenblick A; Kravchenko-Balasha N
Theranostics; 2019; 9(18):5149-5165. PubMed ID: 31410207
[TBL] [Abstract][Full Text] [Related]
3. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
4. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
5. A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients.
Cheng L; Schneider BP; Li L
J Am Med Inform Assoc; 2016 Jul; 23(4):741-9. PubMed ID: 27107440
[TBL] [Abstract][Full Text] [Related]
6. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
Tong L; Mitchel J; Chatlin K; Wang MD
BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
[TBL] [Abstract][Full Text] [Related]
7. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
8. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
9. An integrative multi-omics network-based approach identifies key regulators for breast cancer.
Chen YX; Rong Y; Jiang F; Chen JB; Duan YY; Dong SS; Zhu DL; Chen H; Yang TL; Dai Z; Guo Y
Comput Struct Biotechnol J; 2020; 18():2826-2835. PubMed ID: 33133424
[TBL] [Abstract][Full Text] [Related]
10. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
[TBL] [Abstract][Full Text] [Related]
11. Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes.
Serrano-Carbajal EA; Espinal-Enríquez J; Hernández-Lemus E
Front Oncol; 2020; 10():97. PubMed ID: 32117749
[TBL] [Abstract][Full Text] [Related]
12. Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.
Kim TR; Jeong HH; Sohn KA
BMC Med Genomics; 2019 Jul; 12(Suppl 5):94. PubMed ID: 31296204
[TBL] [Abstract][Full Text] [Related]
13. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
14. Identification of Candidate Genes Associated with Breast Cancer Prognosis.
Xu YH; Deng JL; Wang LP; Zhang HB; Tang L; Huang Y; Tang J; Wang SM; Wang G
DNA Cell Biol; 2020 Jul; 39(7):1205-1227. PubMed ID: 32456464
[TBL] [Abstract][Full Text] [Related]
15. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
Shin SY; Müller AK; Verma N; Lev S; Nguyen LK
PLoS Comput Biol; 2018 Jun; 14(6):e1006192. PubMed ID: 29920512
[TBL] [Abstract][Full Text] [Related]
16. MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.
Xie B; Yuan Z; Yang Y; Sun Z; Zhou S; Fang X
Breast Cancer Res Treat; 2018 Jun; 169(3):625-632. PubMed ID: 29429018
[TBL] [Abstract][Full Text] [Related]
17. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
18. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data.
Khan A; Rehman Z; Hashmi HF; Khan AA; Junaid M; Sayaf AM; Ali SS; Hassan FU; Heng W; Wei DQ
Interdiscip Sci; 2020 Jun; 12(2):155-168. PubMed ID: 32056139
[TBL] [Abstract][Full Text] [Related]
20. Robust pathway-based multi-omics data integration using directed random walks for survival prediction in multiple cancer studies.
Kim SY; Jeong HH; Kim J; Moon JH; Sohn KA
Biol Direct; 2019 Apr; 14(1):8. PubMed ID: 31036036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
